APP下载

熊去氧胆酸与丁二磺酸腺苷蛋氨酸联合治疗乙型肝炎合并妊娠期肝内胆汁淤积症的效果观察

2018-04-08王海燕哈丽亚·哈力木别克

中国现代医生 2018年4期

王海燕 哈丽亚·哈力木别克

[摘要] 目的 探討在乙型肝炎合并妊娠期肝内胆汁淤积症(ICP)患者中联合应用熊去氧胆酸与丁二磺酸腺苷蛋氨酸的临床效果。 方法 选取108例乙型肝炎合并ICP患者,按照随机数字表法分为常规组和联合组,分别给予单纯丁二磺酸腺苷蛋氨酸和抗乙型肝炎病毒(HBV)治疗,在常规组疗法的基础上联合熊去氧胆酸治疗。比较治疗前后症状积分和血清生化指标、临床疗效和不良反应。 结果 治疗后两组症状积分均较治疗前降低(P<0.05),且联合组积分低于常规组(P<0.05);治疗后两组谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TBIL)和总胆汁酸(TBA)均较治疗前降低(P<0.05),且联合组水平低于常规组(P<0.05);联合组综合疗效分布与常规组比较,差异有统计学意义(P<0.05),且联合组临床有效率高于常规组(P<0.05);联合组不良反应发生率稍高于常规组,差异无统计学意义(P>0.05)。 结论 对乙型肝炎合并ICP患者联合给予熊去氧胆酸和丁二磺酸腺苷蛋氨酸治疗能够显著减轻症状和肝功能损害,增强疗效,且并不会明显增多不良反应。

[关键词] 熊去氧胆酸;丁二磺酸腺苷蛋氨酸;乙型肝炎;妊娠期肝内胆汁淤积症

[中图分类号] R714.25 [文献标识码] A [文章编号] 1673-9701(2018)04-0016-04

[Abstract] Objective To investigate the clinical effect of ursodeoxycholic acid combined with ademetionine 1,4-butanedisulfonate in the patients with hepatitis B complicated with intrahepatic cholestasis during pregnancy(ICP). Methods 108 patients with hepatitis B complicated with ICP were divided into routine group and combination group according to random number table. The patients were given simple ademetionine 1,4-butanedisulfonate and anti-hepatitis B virus(HBV) treatment, and were given combined ursodeoxycholic acid on the basis of treatment in the routine group. The symptom scores and serum biochemical indicators before and after treatment, clinical efficacy and adverse reactions were compared. Results After treatment, the symptom scores of both groups were lower than those before treatment(P<0.05), and the scores in the combination group were lower than those in the routine group(P<0.05); after treatment, ALT, AST, TBIL and TBA were lower than those before treatment in both groups(P<0.05), and the levels in the combination group were lower than those in the routine group(P<0.05); the differences were statistically significant in the distribution of comprehensive efficacy between the combination group and the routine group(P<0.05), and the clinical effective rate in the combination group was higher than that in the routine group(P<0.05); the incidence rate of adverse reactions in the combination group was slightly higher than that in the routine group, the differece was no statistically significant(P>0.05).Conclusion The combination of ursodeoxycholic acid and ademetionine 1, 4-butanedisulfonate in the patients with hepatitis B complicated with ICP can significantly reduce the symptoms and liver damage and enhance the efficacy, and does not significantly increase the adverse reactions.

[Key words] Ursodeoxycholic acid;Ademetionine 1,4-butanedisulfonate;Hepatitis B;Intrahepatic cholestasis during pregnancy(ICP)

乙型肝炎是临床上常见的病毒性肝炎,是由乙型肝炎病毒(HBV)感染引发的一种慢性肝损害。ICP是妊娠期的常见病,多发生于妊娠晚期,尤其是在伴有乙型肝炎的孕妇中发生率更高[1]。对于乙型肝炎合并ICP患者来说,肝损害程度加重,且毒性胆汁酸大量分泌,可显著增加不良妊娠结局的发生风险[2]。熊去氧胆酸是ICP患者常用的治疗药物,但是在乙型肝炎合并ICP患者中的应用成效仍需要进一步探讨。鉴于此,本研究特筛选出108例受试者进行分组对照研究,通过观察熊去氧胆酸联合丁二磺酸腺苷蛋氨酸对乙型肝炎合并ICP患者症状、血清生化指标、综合疗效的影响及安全性,评估该方案的应用价值。……

登录APP查看全文